SHANGHAI PHARM.HLDG H YC1 total revenue, net income and dynamics of changes in Euro today
Net revenue of SHANGHAI PHARM.HLDG H YC1 on 31/03/2021 amounted to 51 599 987 610 €. Net income of SHANGHAI PHARM.HLDG H YC1 today amounted to 2 120 145 079 €. Here are the main financial indicators of SHANGHAI PHARM.HLDG H YC1. Schedule of the financial report of SHANGHAI PHARM.HLDG H YC1 for today. The financial graph of SHANGHAI PHARM.HLDG H YC1 displays the online status: net income, net revenue, total assets. All information on SHANGHAI PHARM.HLDG H YC1 total revenue on this chart is created in the form of yellow bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
48 178 031 231.67 €
+12.16 % ↑
1 979 543 417.80 €
+88.23 % ↑
31/12/2020
48 165 563 127.66 €
+24.36 % ↑
834 918 763.87 €
+75.62 % ↑
30/09/2020
49 632 176 665.51 €
+10.65 % ↑
1 082 282 350.57 €
+4.18 % ↑
30/06/2020
43 618 593 960.77 €
+0.32 % ↑
1 311 606 626.16 €
+21.1 % ↑
30/09/2019
44 855 777 053.93 €
-
1 038 830 185.36 €
-
30/06/2019
43 480 218 675.27 €
-
1 083 079 960.48 €
-
31/03/2019
42 955 703 919.96 €
-
1 051 656 713.46 €
-
31/12/2018
38 731 797 900.91 €
-
475 407 609.23 €
-
Show:
to
SHANGHAI PHARM.HLDG H YC1 financial report charts
The dates of the latest financial statements of SHANGHAI PHARM.HLDG H YC1: 31/12/2018, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest date of the financial report of SHANGHAI PHARM.HLDG H YC1 is 31/03/2021. Gross profit SHANGHAI PHARM.HLDG H YC1 is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit SHANGHAI PHARM.HLDG H YC1 is 7 072 317 683 €
SHANGHAI PHARM.HLDG H YC1 quarterly report dates
Cost of revenue SHANGHAI PHARM.HLDG H YC1 is the total cost of producing and distributing of products and services of a company. Cost of revenue SHANGHAI PHARM.HLDG H YC1 is 44 527 669 927 € Total revenue SHANGHAI PHARM.HLDG H YC1 refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue SHANGHAI PHARM.HLDG H YC1 is 51 599 987 610 € Operating income SHANGHAI PHARM.HLDG H YC1 is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income SHANGHAI PHARM.HLDG H YC1 is 1 888 823 920 €
Net income SHANGHAI PHARM.HLDG H YC1 is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income SHANGHAI PHARM.HLDG H YC1 is 2 120 145 079 € Current assets SHANGHAI PHARM.HLDG H YC1 is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets SHANGHAI PHARM.HLDG H YC1 is 112 625 363 699 € Total assets SHANGHAI PHARM.HLDG H YC1 refers to the total amount of assets owned by a person or entity. Total assets SHANGHAI PHARM.HLDG H YC1 is 156 035 001 437 €
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
6 603 302 791.22 €
6 414 670 928.64 €
6 590 192 613.95 €
6 186 159 810.64 €
5 963 939 783.34 €
6 240 954 724.81 €
6 166 128 196.48 €
5 225 631 522.48 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
41 574 728 440.45 €
41 750 892 199.03 €
43 041 984 051.56 €
37 432 434 150.13 €
38 891 837 270.59 €
37 239 263 950.47 €
36 789 575 723.48 €
33 506 166 378.43 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
48 178 031 231.67 €
48 165 563 127.66 €
49 632 176 665.51 €
43 618 593 960.77 €
44 855 777 053.93 €
43 480 218 675.27 €
42 955 703 919.96 €
38 731 797 900.91 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
1 763 562 784.10 €
1 287 192 846.47 €
1 866 505 458.93 €
1 739 341 946.27 €
1 384 070 020.56 €
1 593 268 683.46 €
1 639 485 678.24 €
810 418 261.84 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 979 543 417.80 €
834 918 763.87 €
1 082 282 350.57 €
1 311 606 626.16 €
1 038 830 185.36 €
1 083 079 960.48 €
1 051 656 713.46 €
475 407 609.23 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
387 046 609.14 €
575 649 622.79 €
339 285 385.78 €
313 235 520.84 €
276 050 287.27 €
273 716 927.55 €
253 015 866.42 €
284 624 338.41 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
46 414 468 447.57 €
46 878 370 281.19 €
47 765 671 206.59 €
41 879 252 014.51 €
43 471 707 033.38 €
41 886 949 991.82 €
41 316 218 241.72 €
37 921 379 639.07 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
105 156 387 454.57 €
100 429 675 599.85 €
100 888 363 422.68 €
99 667 479 445.05 €
92 521 258 688.20 €
91 432 545 333.60 €
92 462 372 887.72 €
87 091 973 217.60 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
145 687 228 246.70 €
139 292 110 354.33 €
139 024 493 301.99 €
138 098 951 183.97 €
126 653 502 200.52 €
125 033 390 464.14 €
125 548 621 498.27 €
118 465 077 664.63 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
20 640 609 972.45 €
20 871 992 533.54 €
20 748 021 609.85 €
23 590 309 183.54 €
16 086 728 549.57 €
17 567 492 316.58 €
17 300 723 402.27 €
17 454 894 625.66 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
69 646 687 246.94 €
69 075 889 220.29 €
68 601 543 822.06 €
64 153 142 332.35 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
81 115 099 827.66 €
80 367 869 699.14 €
80 747 655 987.40 €
75 111 122 862.03 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
64.04 %
64.28 %
64.32 %
63.40 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
44 284 758 139.36 €
42 346 891 528.70 €
41 421 855 468.73 €
40 073 501 041.36 €
38 213 566 370.94 €
37 427 127 525.46 €
37 446 497 239.60 €
36 426 307 476.06 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
849 400 487.85 €
1 745 096 575.39 €
143 470 636.39 €
1 308 881 526.67 €
Last revenue report of SHANGHAI PHARM.HLDG H YC1 was 31/03/2021. According to last financial report total revenue in SHANGHAI PHARM.HLDG H YC1 was 48 178 031 231.67 Euro and changed by +12.16% since last year. Net income in SHANGHAI PHARM.HLDG H YC1 was 1 979 543 417.80 € in last quartal, net income changes to +88.23%.
Current cash SHANGHAI PHARM.HLDG H YC1 - the sum of all of the cash a company has on the date of report. Current cash SHANGHAI PHARM.HLDG H YC1 is 22 106 657 155 €
SHANGHAI PHARM.HLDG H YC1 stocks data
S1R.F stock price
SHANGHAI PHARM.HLDG H YC1 stock price today, S1R.F stock quote.
